Supriya Lifescience Ltd. Reports Strong Q2 FY25 Growth with 19% YoY Revenue Increase
Mumbai: The unaudited financial statements for the Q2FY25 results have been released by Supriya Lifescience Ltd., a cGMP-compliant business with a strong track record in API manufacturing and a focus on products from a variety of!-->…
